Date published: 2026-5-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

10074-A4 (CAS 312631-87-1)

0.0(0)
Write a reviewAsk a question

Datasheets
CAS Number:
312631-87-1
Molecular Weight:
409.3
Molecular Formula:
C18H14Cl2N2O3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

QUICK LINKS


10074-A4 (CAS 312631-87-1) References

  1. Ligand clouds around protein clouds: a scenario of ligand binding with intrinsically disordered proteins.  |  Jin, F., et al. 2013. PLoS Comput Biol. 9: e1003249. PMID: 24098099
  2. Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches.  |  Carabet, LA., et al. 2018. Int J Mol Sci. 20: PMID: 30597997
  3. Computational study on natural compounds inhibitor of c-Myc.  |  Ren, J., et al. 2020. Medicine (Baltimore). 99: e23342. PMID: 33327259
  4. A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells.  |  Singh, A., et al. 2021. J Biol Chem. 297: 100903. PMID: 34157284
  5. Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability.  |  Yao, R., et al. 2022. Cell Commun Signal. 20: 73. PMID: 35619182
  6. More is simpler: Decomposition of ligand-binding affinity for proteins being disordered.  |  Wang, X., et al. 2022. Protein Sci. 31: e4375. PMID: 35762723
  7. A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers.  |  Elhasasna, H., et al. 2022. Cells. 11: PMID: 35883689
  8. Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells.  |  Zhou, M., et al. 2023. Molecules. 28: PMID: 37570631
  9. Visualizing single-molecule conformational transition and binding dynamics of intrinsically disordered proteins.  |  Liu, W., et al. 2023. Nat Commun. 14: 5203. PMID: 37626077
  10. Design, synthesis, and activity evaluation of 2-iminobenzimidazoles as c-Myc inhibitors for treating multiple myeloma.  |  Li, S., et al. 2024. Heliyon. 10: e28411. PMID: 38590884

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

10074-A4, 10 mg

sc-507286
10 mg
$429.00